Adiponectin and Leptin Molecular Actions and Clinical Significance in Breast Cancer
Abstract
Obesity is an important public health problem and major risk factor for postmenopausal breast cancer. Adipose tissue is the major component involved in the control of the metabolism through energy homeostasis, adipocyte differentiation, insulin sensitivity and the activation of anti-inflammatory metabolic and immune pathways. Leptin and Adiponectin pathways are involved in proliferation process in breast cancer. Current review describes potential relationship between the molecular actions and clinical significance of leptin and adiponectin in breast cancer.
Wozniak SE, Gee LL, Wachtel MS, Frezza EE, “Adipose tissue: the new endocrine organ? A review article”. Digestive Diseases and Sciences.2009; 54:1847–1856.
Marti A, Berraondo B, Martinez JA, ‘Obese’ protein slims mice. Scienc. 1995; 269:475–476.
Gesta S, Tseng YH, Kahn CR, “Developmental origin of fat: tracking obesity to its source”.Cell. 2007; 131: 242–256.
Juge-Aubry CE, Henrichot E, Meier CA, Adipose tissue: a regulator of inflammation. Best Practice and Research. Clinical Endocrinology and Metabolism. 2005; 19:547–566.
Hu E, Liang P, Spiegelman BM, AdipoQ is a novel adipose-specific gene dysregulated in obesity. J BiolChem. 1996; 271:10697–703.
Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, et al. Organization of the gene for gelatin-binding protein (GBP28). Gene. 1999; 229: 67-73.
Berg AH, Combs TP,Scherer PE,ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism. 2002; 13: 84-89.
Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, et al.PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50: 2094-2099.
Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, et al.Adiponectin and its receptors are expressed in bone-forming cells. Bone. 2004; 35: 842-849.
Weyermann M, Beermann C, Brenner H,Rothenbacher D, Adiponectin and leptin in maternal serum, cord blood, and breast milk. Clinical Chemistry. 2006; 52: 2095-2102.
Katsiougianni S, Kapsogeorgou EK, Manoussakis MN,Skopouli FN, Salivary gland epithelial cells - A new source of the immunoregulatory hormone adiponectin. Arthritis and Rheumatism. 2006; 54: 2295-2299.
Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, et al.Adiponectin is synthesized and secreted by human and murine cardiomyocytes. Febs Letters. 2005; 579: 5163-5169.
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al.Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006; 116: 1784–1792.
Scherer PE, Williams S, Fogliano M, BaldiniLodish HF, A novel serum-protein similar to c1q, produced exclusively in adipocytes. Journal of Biological Chemistry.1995; 270: 26746-26749.
Kishida K, Nagaretani H, Kondo H, Kobayashi H, Tanaka S, et al. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochemical and Biophysical Research Communications. 2003; 306: 286-292.
Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, et al.Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. ProcNatlAcadSci U S A. 2001; 98: 2005-2010.
Simpson F,Whitehead JP, Adiponectin-It's all about the modifications. International Journal of Biochemistry & Cell Biology. 2010; 42: 785-788.
Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic e.ects. Nature. 2003; 423: 762–769.
Weigert J, Neumeier M, Wanninger J, Wurm S, Kopp A, et al.Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. Febs Letters. 2008; 582: 1777-1782.
Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T, et al.Adiponectin acts as an endogenous antithrombotic factor. Arteriosclerosis Thrombosis and Vascular Biology. 2006; 26: 224-230.
Touyz RM, Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection. Circ. Res. 2005; 97:1216–1219.
Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 10308-10313.
Chung Thong Lim, Blerina Kola and Ma´ rtaKorbonits, AMPK as a mediator of hormonal signaling. Journal of Molecular Endocrinology. 2010; 44: 87–97.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8: 1288– 1295.
Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, et al.Characterization of the role of AMP-activated protein kinase in the regulation of glucoseactivated gene expression using constitutively active and dominant negative forms of the kinase. Molecular and Cellular Biology. 2000; 20: 6704–6711.
Kahn BB, Alquier T, Carling D &Hardie DG, AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism. 2005; 1:15–25.
Lopez M, Lelliott CJ & Vidal-Puig A, Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake. BioEssays. 2007; 29: 248–261.
Kuhajda FP,Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000; 16: 202 –208.
Luo Z, Saha AK, Xiang X, Ruderman NB, AMPK, the metabolic syndrome and cancer. Trends PharmacolSci. 2005; 26: 69– 76.
Manning BD, Tee AR, Logsdon MN, Blenis J &CantleyLC, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell. 2002; 10: 151–162.
Inoki K, Li Y, Zhu T,Wu J & Guan KL,TSC2 is phosphorylated and inhibited by Akt and suppresses mTORsignalling. Nat Cell Bio. 2002; l4:648–657.
vanSlegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, et al.Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.HumMol Genet. 1998; 7: 1053–1057.
Goldstein BJ, Scalia R, Adiponectin: A novel adipokine linking adipocytes and vascular function. J ClinEndocrinolMetab.2004; 89: 2563– 2568.
Kelesidis I, Kelesidis T, and Mantzoros CS, Adiponectin and cancer: a systematic review, British Journal of Cancer. 2006; 94: 1221 – 1225.
Chandran M, Phillips SA, Ciaraldi T, Henry RR, Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26:2442–2450.
Miyoshi Y,Funahashi T, Kihara S, Taguchi T, Tamaki Y, et al.Association of serum adiponectin levels with breast cancer risk.Clinical Cancer Research. 2003; 9:5699–5704.
Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, et al.Adiponectin and breast cancer risk.Journal of Clinical Endocrinology and Metabolism. 2004;89:1102–1107.
TworogerSS,HeatherEliassen A, Kelesidis T, Colditz GA, Willett WC, et al.Plasma adiponectin concentrations and risk of incident breast cancer. Journal of Clinical Endocrinology and Metabolism. 2007; 92 1510–1516.
Lippman ME, Endocrine responsive cancers. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology, 9th Ed. Philadelphia: Saunders. 1998; 1675–1692.
Stoll BA, Upper abdominal obesity, insulin resistance and breast cancer risk. Int J ObesRelatMetabDisord. 2002; 26:747–753.
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, et al.Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46:459–469.
Lai A, Sarcevic B, Prall OW, Sutherland RL, Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). Journal of Biological Chemistry. 2001; 276:25823–25833.
Van der Burg B, Rutteman GR, BlankensteinMA, De Laat SW, Van Zoelen EJJ, Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. Journal of Cellular Physiology. 1988;134:101–108.
Bachelder RE, Wendt MA &Mercurio AM, Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Research. 2002; 62:7203–7206.
Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, et al.Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. Journal of Clinical Endocrinology and Metabolism. 2003; 88:4823–4831.
BrakenhielmE,Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, et al.Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. PNAS. 2004; 101:2476–2481.
Körner A, Kratzsch J, Kiess W, Effect of adiponectin on proliferation of breast cancer cells. Experimental and Clinical Endocrinology and Diabetes. 2006; 114 S1 P03_043.
Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, et al.Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Letters. 2006; 237:109–114.
Gulcelik MA, Colakoglu K, Dincer H, Dogan L, Yenidogan E, et al.Associations between adiponectin and two different cancers: breast and colon.Asian Pac J Cancer Prev. 2012; 13(1):395-8.
Sonmez B, Seker M, Bilici A, YavuzErkal F, Oven Ustaalioglu BB, Gumus M, et al. (2011) Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patientswith breast cancer.J BUON. 2011; 16(2):227-32. 51. Seker M, Erkal FY, Bilici A, Salman T, Ustaalioglu BO, et al.The association of tissue and serum adiponectin levels with the parameters of insulin-resistance in breast cancer patients. J ClinOncol. 2009; 27.
Virginia G. Kaklamani, Maureen Sadim, Alex Hsi, Kenneth Offit, Carole Oddoux,Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk.Cancer Res. 2008; 68:3178-3184.
Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, et al.Tissue levels of adiponectin in breast cancer patients.MedOncol.2007; 24(4):361-6.
Shelley Tworoger S, Heather Eliassen A, Theodoros Kelesidis, Graham Colditz A, Walter Willett C, PlasmaAdiponectinConcentrations and Risk of Incident Breast Cancer.JClinEndocrinolMetab. 2007; 92: 1510–1516.
Kang JH, Yu BY, YounDS, Relationship of serum adiponectin and resistin levels with breast cancer risk.J Korean Med Sci. 2007; 22(1):117-21.
Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, et al.Adipocytokines and breast cancer risk.Chin Med J (Engl). 2007; 120(18):1592-6.
Friedman J.M, and Halaas J.L, Leptin and the regulation of body weight in mammals. Nature. 1998; 22:763-770.
Isse N, Ogawa Y, Tamura N, et al.Structural organization and chromosomal assignment of the human obese gene. J BiolChem. 1995; 270:27728–33.
Zhang Y, Basinski MB, Beals JM, et al.Crystal structure of the obese protein leptin-E100. Nature. 1997; 387: 206-209.
Madej T, Boguski MS, Bryant SH, Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 1995; 373: 13-18.
Margetic S, Gazzola C, et al.Leptin: a review of its peripheral actions and interactions. Int J ObesRelatMetabDisord. 2002; 26(11):1407–33.
Matarese G, Moschos S, et al.Leptin in immunology. J Immunol. 2005; 174(6):3137–42.
Fei H, Okano HJ, et al.Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. ProcNatlAcadSci U S A. 1997; 94(13):7001–5.
Lee GH, Proenca R, et al.Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996; 379(6566):632–5.
Tartaglia LA, The leptin receptor. J BiolChem. 1997; 272(10):6093–6.
Hileman SM, Pierroz DD, et al.Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology. 2002; 143(3):775–83.
Elmquist JK, Bjorbaek C, et al.Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neuro. 1998; 395(4):535–47.
Elmquist JK, Elias CF, Saper CB, From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 1999; 22:221–232.
Burcelin R, Kamohara S, Li J, Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in oblobmice. Diabetes. 1999; 48:1264–1269.
Myers Jr M. G, Leptin receptor signaling and the regulation of mammalian physiology. Rec. Prog. Horm. Res. 2004; 59: 287–304.
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, et al.A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute.1995; 87:190–197.
Banks AS, Davis SM, Bates SH, Myers Jr MG, Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 2000; 275:14563–14572.
O'Brien SN, Welter BH, Price TM. Presence of Leptin in Breast Cell Lines and Breast Tumors. Biochemical and Biophysical Research Communications. 1999; 259:695. 74. Kulkarni S, Saxena S, Watroba N, Groth J, Brady W, et al.Prognostic significance of leptin (L) and leptin receptor (OB-R) expression in human breast cancer (BC).Journal of Clinical Oncology. 2006; Vol 24, No. 18S: 20054.
Sulkowska M, Golaszewska J, Wincewicz A, Koda M, Baltaziak M, et al.Leptin - from regulation of fat metabolism to stimulation of breast growth. Pathology Oncology Research. 2006;12:69-72.
Magoffin D, Weitsman S, Aagarawal S, Jakimiuk A, Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. . Ginekologiapolska 1999; 70:1-7.
Castellucci M, Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod. 2000; 6: 951-958.
Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 2006; 8; 237(1):109-14.
Geisler J, Haynes B, Ekse D, Dowsett M, Lønning PE,“Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.” Journal of Steroid Biochemistry and Molecular Biology. 2007; vol. 104, no. 1-2, pp. 27–34.
Harris HR, Tworoger SS, Hankinson SE, Rosner BA, MichelsKB, plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila). 2011; 4(9):1449-56.
Rahmati-Yamchi M, Zarghami N, Rahbani M, Montazeri A, Plasma Leptin, hTERT Gene Expression, and Anthropometric Measures in Obese and Non-Obese Women with Breast Cancer. Breast Cancer (Auckl). 2011; 1; 5:27-35.
KaradumanM, Bilici A, Ozet A, Sengul A, Musabak U, et al. Tissue leptin levels in patients with breast cancer.J BUON. 2010; 15(2):369-72.
Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, et al.Circulating levels of leptin, adiposity and breast cancer risk.Br J Cancer. 2009; 24; 100(4):578-82.
Han CZ, Du LL, Jing JX, Zhao XW, Tian FG, et al. Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China.Biol Trace Elem Res. 2008; 126(1-3):38-48.
Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, et al.Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma.BMC Cancer. 2006; 20: 6-38.
Stattin P, Söderberg S, Biessy C, Lenner P, Hallmans G, et al.Plasma leptin and breast cancer risk: a prospective study in northern Sweden.Breast Cancer Res Treat. 2004; 86(3):191-6.
Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, et al.Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 2000; 5(4):421-6.
Maiti B, Kundranda MN, Spiro TP, Daw HA, The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat. 2010; 121(2):479–83.
Mohan Reddy N, Kalyan Kumar CH, Kaiser Jamil, Obesity, an additional burden for breast cancer patients with leptin gene polymorphisms. American journal of cancer research and clinical oncology. 2013; 1: 18-29.
Mohan Reddy N, Kalyana Kumar CH, Kaiser Jamil, Association of Adiponectin Gene Functional Polymorphisms (+45T/G and 276G/T) with Obese Breast Cancer. J MolBiomarkDiagn. 2012; 3:138.
| Files | ||
| Issue | Vol 8, No 1 (2014) | |
| Section | Articles | |
| Keywords | ||
| Adiponectin Breast Cancer Cytokine Leptin Obesity | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
